Legacy Member Action Alert – Call Governor Murphy!

Jul 3, 2019 | Legislative News

Call-to-Action Alert – Call Governor Murphy

Ask Him to Sign S728/A3717 into Law

On June 27th, the New Jersey Senate & Assembly gave their approval to S728/A3717 which would enact major reforms to strengthen the State MAC law and prohibit retroactive PBM fees, including Brand Effective Rate and Generic Effective Rate. Now that the bill has reached the Governor’s desk, let’s show our unity and solidarity by calling the Governor’s office to ask him to sign S728/A3717 into law. Technically, the Governor has more than 45 days to sign the bill. Please make your call today.

Call Governor Murphy Now to Stop PBM Abuse!

Call Governor Murphy’s Office at 609-292-6000Ask to speak to a Governor’s aide to express your support for the bill
Tell the aide that you support S728/A3717 and request that Governor Murphy to sign this bill into law
Please ask your family, friends, patients and colleagues to call

Don’t Wait – Call Governor Murphy Now & Tell Him that Signing S728/A3717 Will Do the Following:

Protect New Jersey’s Community Pharmacies: Ends retroactive clawbacks of lawful payments made to community pharmacies. This abusive practice of paying for prescriptions and then retroactively reducing the payment several months afterward does extensive damage, disrupting pharmacies’ revenue streams and their ability to continue serving patients.

Provide Drug Price Transparency: Provide patients, pharmacies and businesses with clarity on what they’re actually being charged for prescription drugs by disclosing PBM fees and reimbursements at the point of sale.

Stop Monopolies: Pushes back against big pharmacy benefit manager companies that want to turn the pharmacy system into a monopoly.

Compliance with State Law: The reforms in S728/A3717 are needed because pharmacy benefit managers never complied with the state’s 2015 pharmacy reimbursement transparency law (MAC Law). The current system has become unsustainable for independent community pharmacies and the ability of patients to continue to be able to obtain needed medications from their pharmacy of choice.